Carlsbad-based Verdezyne, which is developing biotechnology used for biofuels production and chemicals manufacturing, has raised $ 10.6M in a new, debt funding round, according to a filing from the firm last week. Details on the funding have not been announced by the company. The filing indicates that Monitor Ventures, OVP Venture Partners, BP Alternative Energy Ltd., and DSM Venturing B.V. all continue to hold seats on the company’s board of directors. Other investors in Verdezyne are the
the Life Science Angels, Seraphim Fund, and the Tech Coast Angels. The funding, and lack of a new board director in the regulatory filing, might indicate the round is a convertible bridge funding to a future round. Verdezyne was previously known as CODA Genomics. READ MORE>>
Apple iPod touch 8 GB 4th Generation (White)The world’s most popular portable gaming device is even more fun. Now available in black and white, iPod touch includes iOS 5 with…
USB Sync and Charging Cable Compatible with Apple iPhone, iPod, iPadUse the Dock Connector to USB Cable to charge and sync your iPhone or iPod with your Mac or Windows PC.
Features :
This USB 2.0 ca…
